Site içinde arama yapın

bir ses eklendi Health

2026-06-10 13:17:03 -

Liposomal Bupivacaine Market Drivers and Opportunities: Increasing Adoption of Non-Opioid Pain Management Therapies

According to market estimates, the Liposomal Bupivacaine Market is projected to grow from US$ 132.15 million in 2025 to US$ 255 million by 2034, registering a CAGR of 8.56% during 2026–2034. Favorable reimbursement frameworks, advanced healthcare infrastructure, and continuous investments in pharmaceutical innovation continue to position North America as a leading regional market...

0 Yorumlar 0 hisse senetleri 326 Views 0 önizleme